Jennifer C Green

US Patent:

6894149, May 17, 2005

Filed:

Oct 10, 2002

Appl. No.:

10/268883

Inventors:

J. Yun Tso - Menlo Park CA, US
Jennifer McPhate Green - Belmont CA, US

Assignee:

Protein Design Labs, Inc. - Fremont CA

International Classification:

C07K016/00

US Classification:

53038822, 5303873, 53038873, 5303888, 53038885, 5303917

Abstract:

This invention provides anti-HLA-DR antibodies and the methods of use thereof for the treatment of leukemia or lymphomas, or solid tumors such as ovarian cancer or melanoma.

US Patent:

20030082188, May 1, 2003

Filed:

Oct 10, 2002

Appl. No.:

10/268882

Inventors:

J. Tso - Menlo Park CA, US
Jennifer Green - Belmont CA, US

International Classification:

A61K039/395
C07K016/30

US Classification:

424/155100, 530/388260

Abstract:

The present invention is directed to a method of treating or detecting prostate cancer or breast cancer in a subject in need of such a treatment or detection by administering an inhibitor of NCAM2 in a pharmaceutically effective amount. The present invention also provides for a pharmaceutical composition comprising an inhibitor of NCAM2.

US Patent:

20030086929, May 8, 2003

Filed:

Oct 10, 2002

Appl. No.:

10/268881

Inventors:

J. Tso - Menlo Park CA, US
Jennifer Green - Belmont CA, US

International Classification:

A61K039/395

US Classification:

424/146100, 424/178100

Abstract:

The present invention is directed to a method of treating or preventing prostate cancer in a subject in need of such a treatment by administering an inhibitor of ATP synthase activity in a pharmaceutically effective amount. The present invention also provides for a pharmaceutical composition comprising an inhibitor of ATP synthase.

US Patent:

20030096285, May 22, 2003

Filed:

Oct 10, 2002

Appl. No.:

10/269010

Inventors:

J. Tso - Menlo Park CA, US
Jennifer Green - Belmont CA, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04
A61K039/395
C12N005/06
C07K016/30

US Classification:

435/006000, 435/007230, 530/388800, 536/023200, 435/344000, 424/155100

Abstract:

The present invention is directed to a method for identifying anti-tumor targets by examining lipid rafts. It provides for a method for identifying anti-tumor targets by lipid raft proteomics and a method for identifying anti-tumor agents by lipid rafts immunization. It also provides for hybridomas produced by the method of identifying anti-tumor agents by lipid raft immunization, and antibodies produced by the hybridomas. It also provides for the anti-tumor targets or agents identified by the methods in the present invention.

US Patent:

20090131317, May 21, 2009

Filed:

Jun 23, 2008

Appl. No.:

12/144584

Inventors:

Yvonne M. Angell - San Carlos CA, US
Ashok Bhandari - Cupertino CA, US
Jennifer Green - Belmont CA, US
Peter J. Schatz - Cupertino CA, US
Christopher P. Holmes - Saratoga CA, US

Assignee:

AFFYMAX, INC. - Palo Alto CA

International Classification:

A61K 38/16
C07K 14/00
C07K 7/08
A61P 35/00
A61P 11/06
A61K 38/10

US Classification:

514 12, 530326, 530327, 530324, 514 13, 514 14

Abstract:

The present invention relates to peptides and compounds that bind to a TRAIL receptor or otherwise act as a TRAIL receptor agonist, as well as methods of treating human diseases using the same. In addition, methods of synthesizing the peptides and compounds described herein are provided by the present invention.

Address:

360 Nueces St APT 1615, Austin, TX 78701

VIN:

WBAVA33537PV65689

Make:

BMW

Model:

3 SERIES

Year:

2007